Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

de Leon J 1 , Schoretsanitis G 2 , Smith RL 3 , Molden E 3 , Solismaa A 4 , Seppälä N 5 Show all authors , Kopeček M 6 , Švancer P 6 , Olmos I 7 , Ricciardi C 8 , Iglesias-Garcia C 9 , Iglesias-Alonso A 10 , Spina E 11 , Ruan CJ 12 , Wang CY 13 , Wang G 13 , Tang YL 14 , Lin SK 15 , Lane HY 16 , Kim YS 17 , Kim SH 18 , Rajkumar AP 19 , González-Esquivel DF 20 , Jung-Cook H 20 , Baptista T 21 , Rohde C 22 , Nielsen J 23 , Verdoux H 24 , Quiles C 24 , Sanz EJ 25 , De Las Cuevas C 26 , Cohen D 27 , Schulte PFJ 27 , Ertuğrul A 28 , Anıl Yağcıoğlu AE 28 , Chopra N 29 , McCollum B 30 , Shelton C 31 , Cotes RO 14 , Kaithi AR 32 , Kane JM 33 , Farooq S 34 , Ng CH 35 , Bilbily J 36 , Hiemke C 37 , López-Jaramillo C 38 , McGrane I 39 , Lana F 40 , Eap CB 41 , Arrojo-Romero M 42 , Rădulescu FŞ 43 , Seifritz E 2 , Every-Palmer S 44 , Bousman CA 45 , Bebawi E 46 , Bhattacharya R 47 , Kelly DL 48 , Otsuka Y 49 , Lazary J 50 , Torres R 51 , Yecora A 52 , Motuca M 53 , Chan SKW 54 , Zolezzi M 55 , Ouanes S 56 , De Berardis D 57 , Grover S 58 , Procyshyn RM 59 , Adebayo RA 60 , Kirilochev OO 61 , Soloviev A 62 , Fountoulakis KN 63 , Wilkowska A 64 , Cubała WJ 64 , Ayub M 65 , Silva A 66 , Bonelli RM 67 , Villagrán-Moreno JM 68 , Crespo-Facorro B 69 , Temmingh H 70 , Decloedt E 71 , Pedro MR 72 , Takeuchi H 73 , Tsukahara M 74 , Gründer G 75 , Sagud M 76 , Celofiga A 77 , Ignjatovic Ristic D 78 , Ortiz BB 79 , Elkis H 80 , Pacheco Palha AJ 81 , LLerena A 82 , Fernandez-Egea E 83 , Siskind D 84 , Weizman A 85 , Masmoudi R 86 , Mohd Saffian S 87 , Leung JG 88 , Buckley PF 89 , Marder SR 90 , Citrome L 91 , Freudenreich O 92 , Correll CU 33 , Müller DJ 29

Affiliations 

  • 1 Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA
  • 2 Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland
  • 3 Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway
  • 4 Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
  • 5 Department of Psychiatry, Satasairaala, Finland
  • 6 National Institute of Mental Health, Klecany, Czech Republic
  • 7 Clinical Pharmacology Unit and Pharmacy Department, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay
  • 8 Clinical Pharmacology Unit and Outpatient Clinic, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay
  • 9 Universidad de Oviedo. CIBERSAM. INEUROPA. ISPA-FIMBA, Oviedo, Spain
  • 10 Hospital Universitario Central de Asturias, Oviedo, Spain
  • 11 Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
  • 12 Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China
  • 13 The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
  • 14 Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA
  • 15 Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
  • 16 Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
  • 17 Department of Neuropsychiatry, Nowon Eulji Medical Center, Eulji University, School of Medicine, Seoul, Korea
  • 18 Department of Psychiatry, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
  • 19 Department of Psychiatry, Christian Medical College, Vellore, India
  • 20 Instituto Nacional de Neurología y Neurocirugía, México City, México
  • 21 Department of Physiology, Los Andes University Medical School, Mérida, Venezuela
  • 22 Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark
  • 23 Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark
  • 24 Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France
  • 25 Department of Physical Medicine and Pharmacology, School of Medicine, Universidad de La Laguna, Canary Islands, Spain
  • 26 Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, and Instituto Universitario de Neurociencia (IUNE), University of La Laguna, Canary Islands, Spain
  • 27 Dutch Clozapine Collaboration Group, Castricum, The Netherlands
  • 28 Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey
  • 29 Addictions Division, Centre for Addiction and Mental Health, Toronto, Canada
  • 30 Eastern State Hospital, Lexington, Kentucky, USA
  • 31 Department of Psychiatry, University of Kentucky, Lexington, KY, USA
  • 32 Hazelwood Center, Louisville, Kentucky, USA
  • 33 The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA
  • 34 School of Medicine, Keele University, Staffordshire, and Midlands Partnership NHS Foundation Trust, Staffordshire, United Kingdom
  • 35 Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia
  • 36 Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA
  • 37 Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Germany
  • 38 Grupo de Investigación en Psiquiatría GIPSI, Departamento de Psiquiatría, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia
  • 39 Department of Pharmacy Practice, University of Montana, Missoula, USA
  • 40 Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona, Spain
  • 41 Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne, Switzerland
  • 42 Department of Psychiatry, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
  • 43 Center for Drug Sciences, Faculty of Pharmacy, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
  • 44 Te Korowai Whāriki Central Regional Forensic Service, Capital and Coast District Health Board, Wellington, New Zealand
  • 45 Departments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences University of Calgary, Alberta, Canada
  • 46 Faculty of Medicine, University of Montreal, Montreal, Canada
  • 47 East London NHS Foundation Trust, London, United Kingdom
  • 48 Department of Psychiatry, School of Medicine, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland, USA
  • 49 Department of Psychiatry, Asahi General Hospital, Chiba, Japan
  • 50 National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary
  • 51 Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
  • 52 Secretaría de Salud Mental y Adicciones, Ministerio de Salud de la Provincia de Jujuy, San Salvador de Jujuy, Argentina
  • 53 Instituto Vilapriño, Center for Studies, Assistance and Research in Neurosciences, Mendoza, Argentina
  • 54 Department of Psychiatry, LSK Faculty of Medicine, The University of Hong Kong, Hong Kong SAR
  • 55 College of Pharmacy, QU Health, Qatar University, Doha, Qatar
  • 56 Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar
  • 57 NHS, Department of Mental Health, "G. Mazzini" Hospital, Teramo, Italy
  • 58 Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India
  • 59 British Columbia Mental Health and Substance Use Research Institute, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
  • 60 Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria
  • 61 Department of Clinical Pharmacology, Astrakhan State Medical University, Astrakhan, Russian Federation
  • 62 Department of Psychiatry and Clinical Psychology, Northern State Medical University, Arkhangelsk, Russia
  • 63 3rd Department of Psychiatry, Division of Neurosciences, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • 64 Department of Psychiatry, Medical University of Gdańsk, Gdańsk, Poland
  • 65 Department of Psychiatry, Queens University, Kingston, Canada
  • 66 Psychiatry Department, Centro Hospitalar Universitário de S. João, Porto, Portugal
  • 67  Sigmund Freud University, Vienna, Austria
  • 68  Department of Neurosciences, Jerez University Hospital, Andalusian Health Service, University of Cadiz, Jerez, Spain
  • 69  Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain
  • 70 Department of Psychiatry and Mental Health, University of Cape Town, Valkenberg Hospital, Western Cape, Cape Town, South Africa
  • 71 Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
  • 72 Hospital Central de Maputo, Maputo, Mozambique
  • 73 Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
  • 74 Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan
  • 75 Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
  • 76 Department of Psychiatry, School of Medicine, University of Zagreb, Zagreb, Croatia
  • 77 Department of Psychiatry, University Medical Centre Maribor, Maribor, Slovenia
  • 78 University of Kragujevac, Faculty of Medical Sciences, Department of Psychiatry, Kragujevac, Serbia
  • 79 Group of Resistant Schizophrenia (GER), Schizophrenia Program (Proesq), Federal University of Sao Paulo, SP, Brazil
  • 80 Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Sao Paulo, Brazil
  • 81 Department and Institute of Psychiatry and Mental Health, Oporto Faculty of Medicine, Oporto, Portugal
  • 82 INUBE Biosanitary Research Institute of Extremadura. Extremadura University Hospital and Medical School, Badajoz, Spain
  • 83 Cambridge Psychosis Centre, Cambrigeshire and Peterborough NHS Foundation Trust & Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
  • 84 Metro South Addiction and Mental Health Service, Brisbane, Australia
  • 85 Research Unit, Geha Mental Health Center and Molecular Psychiatry Laboratory, Felsenstein Medical Research Center, Tel Aviv, Israel
  • 86 Psychiatry "A" Department, Hedi Chaker University Hospital, Sfax, Tunisia
  • 87 Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
  • 88 Department of Pharmacy, Mayo Clinic, Rochester, MN, USA
  • 89 School of Medicine, Virginia Commonwealth University, Richmond, VA, USA
  • 90 Semel Institute for Neuroscience at UCLA, Los Angeles, CA, USA
  • 91 New York Medical College, Department of Psychiatry and Behavioral Sciences, Valhalla, NY, USA
  • 92 Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Pharmacopsychiatry, 2022 Jan 20.
PMID: 35052001 DOI: 10.1055/a-1737-1527

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications